Masitinib

PARIS, July 10, 2026 AB Science announced a major strategic update to its clinical development pipeline, confirming that it...

PARIS, October 17, 2025 AB Science S.A., a biopharmaceutical company focused on discovering, developing, and marketing protein kinase inhibitors,...